3/4 inhibitor – now given the somewhat tongue-twisting brand name of Ohtuvayre – is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
The parents of Cole Schmidtknecht are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the 22-year-old ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...
Cole Schmidtknecht had chronic asthma since he was a child, and had used a steroid inhaler to control his symptoms for more ...
A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family. Cole Schmidtknecht, 22, suffered from asthma ...
Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.
Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to increase its ...
The demand for inhalation and nasal spray generic drugs is growing as these medications provide affordable and effective treatment options for respiratory ailments like asthma, COPD, and allergies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback